Skip to main content
HimalayasHimalayas logo
KyvernaKY

Associate Director, SEC Reporting & Technical Accounting

Kyverna Therapeutics is a biopharmaceutical company focused on developing innovative CAR T-cell therapies for autoimmune diseases.

Kyverna

Employee count: 51-200

Salary: 165k-185k USD

United States only

Stay safe on Himalayas

Never send money to companies. Jobs on Himalayas will never require payment from applicants.

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.

Position Overview

Kyverna Therapeutics is seeking a highly motivated, hands-on, and detail-oriented Associate Director, SEC Reporting & Technical Accounting to join the Finance organization reporting to the VP, Corporate Controller. This individual will play a critical role in leading the Company’s SEC reporting, technical accounting, SOX compliance, and operational accounting activities within a dynamic and rapidly evolving public biotechnology environment.

This position is ideal for a proactive CPA with deep expertise in U.S. GAAP and SEC reporting, including candidates with a strong foundation in public accounting, audit, or accounting advisory services who are seeking broader exposure across operational and strategic accounting functions within the life sciences industry.

The successful candidate will partner cross-functionally with Finance, Legal, HR, IT, Stock Administration, Investor Relations, external auditors, and third-party advisors while supporting the Company’s continued growth, governance initiatives, and commercial readiness efforts.

Department: Finance
Location: Remote eligible
Reports To: VP, Accounting & Business Operations

Responsibilities

    SEC Reporting & Financial Reporting

    • Lead the preparation and review of quarterly and annual SEC filings, including Forms 10-Q, 10-K, 8-K, S-8, supporting disclosures, and related tie-out documentation and reporting workbooks

    • Prepare and review key financial statement areas and disclosures, including:

    • Lease accounting (ASC 842)
    • Share-based compensation (ASC 718)
    • Available-for-sale investments
    • Statement of cash flows
    • Stockholders’ equity roll forwards
    • • Manage the Company’s quarterly and annual reporting calendar and coordinate cross-functional deliverables with Legal, Investor Relations, Finance, and external stakeholders to ensure timely and accurate SEC filings

      • Serve as a key point of contact for external auditors and SOX auditors in connection with quarterly reviews, annual audits, and ongoing compliance activities

      • Assist in the preparation of Audit Committee and Disclosure Committee materials and presentations, as needed

      • Lead and coordinate SOX compliance initiatives, partnering with internal process owners, external auditors, and SOX consultants to support ongoing compliance and control effectiveness

      • Maintain and enhance SOX documentation, including narratives, process flows, and risk control matrices (RCMs)

      Technical Accounting

      • Research, analyze, and document technical accounting conclusions under U.S. GAAP for complex and non-routine transactions

      • Prepare technical accounting memoranda and supporting analyses related to lease accounting under ASC 842, including lease modifications and reassessments

      • Partner with the VP, Corporate Controller and third-party advisors on technical accounting assessments related to financing transactions, strategic agreements, and other complex accounting matters

      • Support operational and cross-functional teams with technical accounting guidance related to inventory, cost capitalization, debt accounting, collaboration agreements, new accounting pronouncements, and other business initiatives

      • Perform technical accounting calculations and analyses related to share-based compensation accounting under ASC 718, including equity award modifications and Black-Scholes fair value calculations

      • Conduct quarterly contract reviews to identify accounting implications and ensure appropriate accounting treatment and documentation

      Operational & Strategic Support

      • Support selected stock administration and payroll-related accounting review activities

      • Assist with accounting and reporting for debt and equity financings, licensing and collaboration agreements, and other strategic transactions

      • Participate in process improvement initiatives, automation efforts, and system implementations to support scalability and operational efficiency within a growing public company environment

      • Contribute to ad hoc analyses, special projects, and broader Finance organization initiatives, as needed

Qualifications

    • Bachelor’s degree in Accounting or Finance required

    • Active CPA license required

    • 10+ years of progressive accounting experience, including experience serving SEC registrants within public accounting and/or accounting advisory environments

    • Big Four or national public accounting firm experience strongly preferred

    • Strong technical knowledge of U.S. GAAP, SEC reporting requirements, and public company compliance obligations

    • Demonstrated experience preparing technical accounting memoranda and analyzing complex accounting transactions

    • Experience supporting SOX 404(b) compliance programs and internal control frameworks

    • Biotechnology, pharmaceutical, or life sciences industry experience preferred, but not required

    • Strong Excel, financial systems, and reporting tool experience; Workiva experience is a plus

    • Excellent organizational, project management, and communication skills with the ability to manage multiple priorities in a fast-paced environment

    • Collaborative, team-oriented mindset with a willingness to roll up sleeves and support broader team initiatives

    • Ability to remain highly detail-oriented, hands-on, and execution-focused while operating strategically in a growing organization

The national salary range for this position is from $165,000 to $185,000 USD annually. This salary range is an estimate of what we reasonably expect to pay for this posted position, and the actual salary may vary based on various factors, including without limitation individual education, experience, tenure, skills and abilities, as well as internal equity and alignment with market data. This position is also eligible for bonus, benefits, and participation in Company’s stock plan.

About the job

Apply before

Posted on

Job type

Full Time

Experience level

Salary

Salary: 165k-185k USD

Education

Bachelor degree
Professional certificate

Experience

10 years minimum

Location requirements

Hiring timezones

United States +/- 0 hours

About Kyverna

Learn more about Kyverna and their company culture.

View company profile

Our mission is to liberate autoimmune patients through the curative potential of cell therapy. A new era of CAR T-cell therapy, Kyverna is pioneering a durable disease-clearing approach aiming for deep B cell depletion, an immune system reset, and long-term remission in autoimmune diseases. We believe the success of CAR T-cell therapies in B cell-driven hematological malignancies can be leveraged to deliver therapeutic benefits in patients living with autoimmune diseases.

We are a patient-centered, clinical-stage biopharmaceutical company with active, ongoing clinical trials for multiple autoimmune diseases at different locations across the world. Our lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical development with sponsored clinical trials across two broad areas of autoimmune disease: rheumatology and neurology. This includes Phase 2 trials for stiff person syndrome, multiple sclerosis, and myasthenia gravis, as well as two ongoing multi-center, open-label Phase 1/2 trials in the United States and Germany for patients with lupus nephritis. Kyverna's pipeline includes next-generation chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats, specifically designed for use in B cell-driven autoimmune diseases.

Claim this profileKyverna logoKY

Kyverna

View company profile

Similar remote jobs

Here are other jobs you might want to apply for.

View all remote jobs

20 remote jobs at Kyverna

Explore the variety of open remote roles at Kyverna, offering flexible work options across multiple disciplines and skill levels.

View all jobs at Kyverna

Remote companies like Kyverna

Find your next opportunity by exploring profiles of companies that are similar to Kyverna. Compare culture, benefits, and job openings on Himalayas.

View all companies

Find your dream job

Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!

Sign up
Himalayas profile for an example user named Frankie Sullivan